238 results on '"De La Taille A"'
Search Results
2. Contribution of canine olfaction in the diagnostic strategy of intermediate and high-risk prostate cancer: a double-blind validation study
3. Open versus robotic partial nephrectomy in obese patients: a multi-institutional propensity score-matched analysis (UroCCR 43—Robese study)
4. Surgical metastasectomy for metastatic renal cell carcinoma in the era of targeted and immune therapy: a narrative review
5. Intraoperative complication of radical cystectomy for muscle-invasive bladder cancer: does the surgical approach matter? A retrospective multicenter study using the EAUiaiC classification
6. Urethrectomy at the time of radical cystectomy for non-metastatic urothelial carcinoma of the bladder: a collaborative multicenter study
7. Neoadjuvant treatment with androgen receptor signaling inhibitors prior to radical prostatectomy: a systematic review
8. Comorbidity and frailty assessment in renal cell carcinoma patients
9. Contemporary use of phytotherapy in patients with lower urinary tract symptoms due to benign prostatic hyperplasia: results from the EVOLUTION European registry
10. Comparison of the iliac, vaginal and umbilical graft extraction in robot-assisted laparoscopic living donor nephrectomy
11. Environmental impact of current endoscopic technology in urological procedures: a systematic review on reusable vs. disposable scopes.
12. Preliminary assessment of patient and physician satisfaction with the use of teleconsultation in urology during the COVID-19 pandemic
13. Polyethylene glycol-based hydrogel rectal spacers for prostate brachytherapy: a systematic review with a focus on technique
14. Quality of life with pharmacological treatment in patients with benign prostatic enlargement: results from the Evolution European Prospective Multicenter Multi-National Registry Study
15. Robotic versus open radical cystectomy throughout the learning phase: insights from a real-life multicenter study
16. En bloc greenlight laser enucleation of prostate (GreenLEP): about the first hundred cases
17. Androgenic hormones and the excess male mortality observed in COVID-19 patients: new convergent data
18. Outcomes after salvage radical prostatectomy and first-line radiation therapy or HIFU for recurrent localized prostate cancer: results from a multicenter study
19. Medical therapy versus transurethral resection of the prostate (TURP) for the treatment of symptomatic benign prostatic enlargement (BPE): a cost minimisation analysis
20. Perioperative outcomes and complications of intracorporeal vs extracorporeal urinary diversion after robot-assisted radical cystectomy for bladder cancer: a real-life, multi-institutional french study
21. Prostatic injection of botulinum toxin is not inferior to optimized medical therapy in the management of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a randomized clinical trial
22. Integration of MRI to clinical nomogram for predicting pathological stage before radical prostatectomy
23. Improved decision making in intermediate-risk prostate cancer: a multicenter study on pathologic and oncologic outcomes after radical prostatectomy
24. Trends of lymphadenectomy in upper tract urothelial carcinoma (UTUC) patients treated with radical nephroureterectomy
25. Postoperative drainage does not prevent complications after robotic partial nephrectomy
26. Early results and complications of prostatic arterial embolization for benign prostatic hyperplasia
27. What do we know about treatment sequencing of abiraterone, enzalutamide, and chemotherapy in metastatic castration-resistant prostate cancer?
28. The morbidity of laparoscopic radical cystectomy: analysis of postoperative complications in a multicenter cohort by the European Association of Urology (EAU)-Section of Uro-Technology
29. The use of hemostatic agents does not prevent hemorrhagic complications of robotic partial nephrectomy
30. Oncological outcomes of advanced muscle-invasive bladder cancer with a micropapillary variant after radical cystectomy and adjuvant platinum-based chemotherapy
31. Predicting the risk of harboring high-grade disease for patients diagnosed with prostate cancer scored as Gleason ≤ 6 on biopsy cores
32. Bipolar plasma vaporization of the prostate: ready to replace GreenLight? A systematic review of randomized control trials
33. Location, extent, and multifocality of positive surgical margins for biochemical recurrence prediction after radical prostatectomy
34. Impact of micropapillary histological variant on survival after radical nephroureterectomy for upper tract urothelial carcinoma
35. Contemporary pathologic characteristics and oncologic outcomes of prostate cancers missed by 6- and 12-core biopsy and diagnosed with a 21-core biopsy protocol
36. Extraperitoneal robot-assisted laparoscopic radical prostatectomy: a single-center experience beyond the learning curve
37. A switch from GnRH agonist to GnRH antagonist in castration-resistant prostate cancer patients leads to a low response rate on PSA
38. Environmental impact of current endoscopic technology in urological procedures: a systematic review on reusable vs. disposable scopes
39. The impact of lymph node status and features on oncological outcomes in urothelial carcinoma of the upper urinary tract (UTUC) treated by nephroureterectomy
40. Biopsy and treatment decisions in the initial management of prostate cancer and the role of PCA3; a systematic analysis of expert opinion
41. Impact of the primary Gleason pattern on biochemical recurrence-free survival after radical prostatectomy: a single-center cohort of 1,248 patients with Gleason 7 tumors
42. Impact of oral anticoagulation on morbidity of transurethral resection of the prostate
43. High-grade prostatic intraepithelial neoplasia and atypical small acinar proliferation on initial 21-core extended biopsy scheme: incidence and implications for patient care and surveillance
44. Retroperitoneal laparoscopic radical nephrectomy: Intermediate oncological results
45. Analysis of complications from 600 retroperitoneoscopic procedures of the upper urinary tract during the last 10 years
46. The NF-κB/IL-6 pathway in metastatic androgen-independent prostate cancer: new therapeutic approaches?
47. Comorbidity and frailty assessment in renal cell carcinoma patients
48. Contemporary use of phytotherapy in patients with lower urinary tract symptoms due to benign prostatic hyperplasia: results from the EVOLUTION European registry
49. Comparison of the iliac, vaginal and umbilical graft extraction in robot-assisted laparoscopic living donor nephrectomy
50. Saturation biopsy protocol enhances prediction of pT3 and surgical margin status on prostatectomy specimen
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.